Pneumocystis carinii glycoprotein A inhibits surfactant phospholipid secretion by rat alveolar type II cells

Journal of Infectious Diseases

Volumn 177, Issue 1, 1998, Pages 182-187

  Lipschik, Gregg Y ^a   Treml, John F ^b   Moore, Sean D ^b   Beers, Michael F ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DIPALMITOYLPHOSPHATIDYLCHOLINE; GLYCOPROTEIN; LUNG SURFACTANT; MONOCLONAL ANTIBODY; PHOSPHOLIPID; TRITIUM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; LUNG ALVEOLUS CELL TYPE 2; NONHUMAN; PATHOGENESIS; PHOSPHOLIPID METABOLISM; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROTOZOAL INFECTION; RAT; VIRUS INFECTION;

EID: 0031975944     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513826     Document Type: Article

References (15)

1. Kernbaum S, Masliah J, Alcindor LG, Bouton C, Christol D. Phospholipase activities of bronchoalveolar lavage fluid in rat Pneumocystis carinii pneumonia. Br J Exp Pathol 1983;64:75-80.
2. Phelps DS, Rose RM. Increased recovery of surfactant protein A in AIDS-related pneumonia. Am Rev Respir Dis 1991;143:1072-5.
3. Hoffman AGD, Lawrence M, Ognibene FP, et al. Reduction of pulmonary surfactant in patients with human immunodeficiency viras infection and Pneumocystis carinii pneumonia. Chest 1992;102:1730-6.
4. Rose RM, Catalano PJ, Koziel H, Furlong ST. Abnormal lipid composition of bronchoalveolar lavage fluid obtained from individuals with AIDS-related lung disease. Am J Respir Crit Care Med 1994;149:332-8.
5. Phelps DS, Umstead TM, Rose RM, Fishman JA. Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat. Eur Respir J 1996;9:565-70.
6. Rice WR, Singleton FM, Linke MJ, Walzer PD. Regulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat. J Clin Invest 1993;92:2778-82.
7. Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. FASEB J 1994;8:957-67.
8. Pottratz ST, Paulsrud J, Martin WJ II. Pneumocystis carinii membrane glycoprotein gp120 is a fibronectin binding protein which mediates Pneumocystis attachment [abstract]. Clin Res 1990;38:466A.
9. Limper AH, Pottratz ST, Martin WJ II. Modulation of Pneumocystis carinii adherence to cultured lung cells by a mannose-dependent mechanism. J Lab Clin Med 1991;118:492-9.
10. Hoffman OA, Standing JE, Limper AH. Pneumocystis carinii stimulates tumor necrosis factor-α release from alveolar macrophages through a β-glucan-mediated mechanism. J Immunol 1993;150:3932-40.
11. Zimmerman PE, Voelker DR, McCormack FX, Martin WJ. The 120 kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest 1992;86:143-9.
12. Gigliotti F, Hughes WT. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J Clin Invest 1988;81:1666-8.
13. Kovacs JA, Powell F, Edman JC, et al. Multiple genes encode the major surface glycoprotein of Pneumocystis carinii. J Biol Chem 1993;268:6034-40.
14. Angus CW, Tu A, Vogel P, Qin M, Kovacs JA. Expression of variants of the major surface glycoprotein of Pneumocystis carinii. J Exp Med 1996;183:1229-34.
15. Gigliotti F, Stokes DC, Cheatham AB, Davis DS, Hughes WT. Development of murine monoclonal antibodies to Pneumocystis carinii. J Infect Dis 1986;154:315-22.